| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $6.22B | +21.0% |
| R&D Expense | $2.27B | +20.8% |
| SG&A Expense | $604.1M | +24.3% |
| Operating Income | -$222.2M | -90.8% |
| Interest Expense | $102.4M | +516.5% |
| Pre-tax Income | -$259.9M | -1706.4% |
| Income Tax | $106.8M | +909.6% |
| Net Income | -$366.7M | -1348.6% |
| EPS (Basic) | -$1.44 |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.89B | +22.9% |
| Short-term Investments | $4.24B | +100.7% |
| Accounts Receivable | $1.57B | +26.4% |
| Current Assets | $8.11B | +55.5% |
| Total Assets | $13.49B | +28.5% |
| Current Liabilities | $4.63B | -8.7% |
| Long-term Debt | $2.98B | +61.8% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.66B | +0.4% |
| Investing Cash Flow | -$2.51B | -55.9% |
| Financing Cash Flow | $1.20B | +991.9% |
| -1300.0% |
| EPS (Diluted) | -$1.44 | -1300.0% |
| Total Liabilities |
| $7.90B |
| +32.5% |
| Stockholders' Equity | $5.59B | +23.2% |